🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of ...
Status
Recruiting
Location
Beijing Tongren Hospital, Capital Medical University
Start Date
2024-03-18
Trial ID
NCT06300203
Treatments Being Tested
This is a single center, randomized, double-blind, placebo-controlled, dose...
Status
Completed
Location
PKUCare Luzhong Hospital
Start Date
2019-09-03
Trial ID
NCT06161090
This is a multi-center, single arm, open label phase 3 study to evaluate th...
Status
Active Not Recruiting
Location
Peking University People's hospital
Start Date
2024-08-02
Trial ID
NCT06495229
Treatments Being Tested
This study is a multi-center, randomized, double-blind, placebo-controlled ...
Status
Recruiting
Location
China-Japan Friendship Hospital
Start Date
2023-04-28
Trial ID
NCT05761028
This is a single-center, randomized, open-label study to evaluate the pharm...
Status
Unknown
Location
The Second Hospital of Anhui Medical University
Start Date
2024-04-30
Trial ID
NCT06171048
Treatments Being Tested
This study aims to explore the efficacy and safety of scipibaimab combined ...
Status
Not Yet Recruiting
Location
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center
Start Date
2026-02
Trial ID
NCT07388758
Treatments Being Tested
This is a multi-center, single arm, open-label study to evaluate safety and...
Status
Completed
Location
Beijing Children's Hospital Capital Medical University
Start Date
2022-10-07
Trial ID
NCT05579925
Treatments Being Tested
This study is a multi-center, randomized, double-blind, parallel controlled...
Status
Completed
Location
Hangzhou First People's Hospital
Start Date
2023-03-10
Trial ID
NCT05715320
Treatments Being Tested
This is a multi-center, open-label phase 2 study to evaluate the long-term ...
Status
Completed
Location
Peking University People's Hospital
Start Date
2023-12-21
Trial ID
NCT06116565
Treatments Being Tested